San Francisco, CA, United States of America

Kimberly Kirkwood

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of California. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kimberly Kirkwood. Retrieved from https://idiyas.com/inventor/kimberly-kirkwood

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kimberly Kirkwood: Innovator in Pancreatic Cancer Diagnosis

Introduction

Kimberly Kirkwood is a prominent inventor based in San Francisco, California. She has made significant contributions to the field of medical diagnostics, particularly in the detection of pancreatic cancer. Her innovative work focuses on identifying molecular biomarkers that can aid in the diagnosis of this challenging disease.

Latest Patents

Kirkwood holds a patent titled "Compositions and methods of diagnosing pancreatic cancer." This patent relates to the detection of molecular biomarkers in a sample, specifically aimed at identifying biomarkers for pancreatic cysts. Her work is crucial in improving diagnostic methods and potentially enhancing patient outcomes.

Career Highlights

Kirkwood is affiliated with the University of California, where she continues her research and development in the field of cancer diagnostics. Her dedication to advancing medical science is evident in her innovative approaches and commitment to improving healthcare.

Collaborations

Throughout her career, Kirkwood has collaborated with esteemed colleagues, including Charles S. Craik and Anthony J. O'Donoghue. These partnerships have further enriched her research and contributed to the advancement of diagnostic techniques.

Conclusion

Kimberly Kirkwood's work in diagnosing pancreatic cancer through molecular biomarkers represents a significant advancement in medical diagnostics. Her contributions are vital in the ongoing fight against cancer, and her innovative spirit continues to inspire future research in this critical area.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…